Send me a link:

*Text messaging rates may apply.

 Dow Down0.19% Nasdaq Up0.45%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
5.08 0.11(2.12%) Jul 30, 3:59PM EDT
|After Hours : 5.12 Up 0.04 (0.79%) Jul 30, 7:50PM EDT
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Assets
Current Assets
Cash And Cash Equivalents98,121  78,332  101,749  
Short Term Investments78,875  59,071  45,844  
Net Receivables -   -   -  
Inventory -   -   -  
Other Current Assets1,286  1,491  1,126  
Total Current Assets 178,282   138,894   148,719  
Long Term Investments -   -   -  
Property Plant and Equipment630  83  439  
Goodwill -   -   -  
Intangible Assets -   -   -  
Accumulated Amortization -   -   -  
Other Assets1,209  177  542  
Deferred Long Term Asset Charges -   -   -  
Total Assets 180,121   139,154   149,700  
Liabilities
Current Liabilities
Accounts Payable19,424  21,685  4,277  
Short/Current Long Term Debt -   -   -  
Other Current Liabilities3,429  3,429  3,429  
Total Current Liabilities 22,853   25,114   7,706  
Long Term Debt80,031   -   -  
Other Liabilities232   -  288  
Deferred Long Term Liability Charges35,143  38,571  42,000  
Minority Interest -   -   -  
Negative Goodwill -   -   -  
Total Liabilities 138,259   63,685   49,994  
Stockholders' Equity
Misc Stocks Options Warrants -   -   -  
Redeemable Preferred Stock -   -   -  
Preferred Stock -   -   -  
Common Stock105  84  61  
Retained Earnings(514,475)(436,804)(346,710)
Treasury Stock -   -   -  
Capital Surplus556,235  512,174  446,357  
Other Stockholder Equity(3)15  (2)
Total Stockholder Equity 41,862   75,469   99,706  
Net Tangible Assets 41,862   75,469   99,706  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.